Skip to content

Assesment and optimising psychosocial care for persons with Li-Fraumeni syndrome and their relatives as part of the intensified screening and follow-up programme

Assesment and optimising psychosocial care for persons with Li-Fraumeni syndrome and their relatives as part of the intensified screening and follow-up programme

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00021040
Enrollment
100
Registered
2021-04-12
Start date
2020-03-11
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer predispostion Pathogenic TP53 germline variant C97 Z80

Interventions

Group 1: People with LiFraumeni Syndrome (LFS) relaitves of peoole with Li-Fraumeni syndrome are questioned about psychosozial aspects regarding LFS -paper-based, APP Based and viwa interviews

Sponsors

Universitätsfrauenklinik Heidelberg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 120 Years

Inclusion criteria

Inclusion criteria: Diagnosis of LFS, Li-Fraumeni-Like-Syndrome, pathogenic TP53 germline variant - OR - Relatives (relative, partner, close person) - From the age of 18 - German as mother tongue or very good knowledge of German - Existence of an informed written consent to participate in the study

Exclusion criteria

Exclusion criteria: unclassified variant in the TP 53 germline (VUS), <18 years, not able to provide written informed consent, missing buisness capability, no sufficeint german language skills, unablility to pariticpate in interviews or answer questionairs, missing informed consent

Design outcomes

Primary

MeasureTime frame
The primary aim of this study is: a) the needs assesment for improving the medical and psychosocial care of people with LFS and their close relatives, who form the overall study group. b) Feasibility and adherence to app support by the surveillance for people with LFS. c) What is the state anxiety trend of people with LFS in respect to the surveillancve?

Secondary

MeasureTime frame
Secondary target criteria 1. Cancer worry 2. Qualitiy of Life 3. To what extent occur psychopathologies in those affected or related personals?

Countries

Germany

Contacts

Public ContactImad Maatouk

Universitätsklinikum Heidelberg

imad.maatouk@med.uni-heidelberg.de06221 560

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026